Platinum-refractory oral cancers could have a poorer therapeutic response to immunotherapy than their non-oral counterparts

Research output: Contribution to journalLetterpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)779-780
Number of pages2
JournalCancer Research, Statistics, and Treatment
Issue number4
Publication statusPublished - 01-10-2022

All Science Journal Classification (ASJC) codes

  • Ophthalmology
  • Drug guides
  • Oncology(nursing)
  • Cancer Research

Cite this